ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Verastem
The Director, Clinical Scientist leads oncology study design, execution, and data interpretation, authoring key regulatory documents and guiding program strategy. This role partners with cross‑functional teams, CROs, and investigators to ensure data integrity, compliance, and effective scientific communication.
Headquarters
Needham Heights, Massachusetts, United States
Company Size
51-200 employees
Founded
2010
Verastem Oncology is a biopharmaceutical company focused on developing and delivering novel therapies for RAS/MAPK pathway-driven cancers. The company has advanced the first FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer and maintains a pipeline of small molecule inhibitors targeting KRAS G12D, RAF/MEK, and FAK pathways. Verastem leverages strategic collaborations and ongoing clinical trials to address significant unmet needs across multiple solid tumor types.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Verastem.
Right around the average for this role
Director, Clinical Science – Oncology Clinical Development
GSK plc
Clinical Research Scientist
LanceSoft
Director, Clinical Science – Oncology Clinical Development
GSK plc
Associate Director, Clinical Scientist
Madrigal Pharmaceuticals
Clinical Scientist
Perspective Therapeutics
Scientific Director, Oncology Early Development
AbbVie